Orchid Lifescience India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-12-2024
- Paid Up Capital ₹ 0.50 M
as on 16-12-2024
- Company Age 12 Year, 27 Days
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 0.50 M
as on 16-12-2024
About Orchid Lifescience India
The Corporate was formerly known as Cheiron Pharmaceuticals Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹0.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sharad Koli and Sumedh Potdar serve as directors at the Company.
- CIN/LLPIN
U24233PN2012PTC145516
- Company No.
145516
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Orchid Lifescience India Private Limited offer?
Orchid Lifescience India Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Body Care Products, Child and Baby Care Products, Baby Care Products.
Who are the key members and board of directors at Orchid Lifescience India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumedh Potdar  | Managing Director | 26-Nov-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharad Koli | Director | 25-Oct-2013 | Current |
Financial Performance of Orchid Lifescience India.
Orchid Lifescience India Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Orchid Lifescience India?
Unlock access to Orchid Lifescience India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 03 Jan 2017 | ₹0.50 M | Satisfied |
How Many Employees Work at Orchid Lifescience India?
Unlock and access historical data on people associated with Orchid Lifescience India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orchid Lifescience India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orchid Lifescience India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
